Mosaic Technologies raises $6 million:
This article was originally published in Clinica
Executive Summary
Privately-owned Mosaic Technologies has received $6 million from a group of venture capitalists and private investors. The Boston-based company develops DNA-based diagnostic products for the blood and plasma screening and clinical testing research markets. The company is developing a device to test blood products for bacterial contamination.